Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Vivus, Inc. (NQ: VVUS)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(VVUS) Community Analysis from
April 18, 2014
(Stock Blog Hub, 2/25/13)
Vivus, Inc. (VVUS) recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) re-examined and...(read more)
(Stock Wizard, 1/7/13)
Shares of Vivus Inc (NASDAQ: VVUS) surged as much as 10% on Monday after the company disclosed in a regulatory filing that prescriptions for its flagship obesity drug Qsymia jumped 68% to 12,978 for... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
(Stock Blog Hub, 11/9/12)
Vivus Inc. (VVUS) reported a loss of 40 cents per share in the third quarter of 2012, wider than the Zacks Consensus Estimate of a loss of 33 cents and the year-ago loss of 10 cents...(read more)
Vivus (VVUS) Company Overview

There is no analysis for VVUS yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here